Literature DB >> 3096516

[Functional inhibition by cyclosporin A of the lymphocyte receptor for the AIDS virus (HIV)].

D Klatzmann, J P Laporte, A Achour, E Brisson, J Gruest, L Montagnier, J C Gluckman.   

Abstract

The Human Immunodeficiency Virus (HIV) displays a selective tropism for cells expressing the CD4 molecule which, by itself, represents at least part of the specific receptor for this virus. However, modification of the activation state of each individual cell seems critical not only for virus replication but also for its binding and subsequent penetration into its target. We demonstrate here that Cyclosporin-A (CSA), a drug which inhibits IL-2 dependent T-lymphocyte proliferation and differentiation and which is known for its immunosuppressive activity, can prevent subsequent virus binding to cells otherwise susceptible to HIV. Normal T-lymphocytes were preincubated in vitro with CSA at concentrations that were in the same range than those reached in the serum of treated patients. This resulted in the complete disappearance of HIV receptors (HIV-R), as assessed by the direct measure of specific binding of fluoresceinated HIV (HIV-FITC), and in the subsequent inhibition of HIV replication in cultured cells. Moreover CSA pretreatment of IL-2 independent transformed cells derived from the CEM line, before their infection, strongly inhibited HIV adsorption as well as further virus replication. These results provide a new experimental basis for the potential application of CSA in the treatment of HIV-related diseases.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3096516

Source DB:  PubMed          Journal:  C R Acad Sci III        ISSN: 0764-4469


  6 in total

1.  Inhibition of human immunodeficiency virus and growth of infected T cells by the immunosuppressive drugs cyclosporin A and FK 506.

Authors:  A Karpas; M Lowdell; S K Jacobson; F Hill
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-01       Impact factor: 11.205

2.  Mode of action of SDZ NIM 811, a nonimmunosuppressive cyclosporin A analog with activity against human immunodeficiency virus type 1 (HIV-1): interference with early and late events in HIV-1 replication.

Authors:  A Steinkasserer; R Harrison; A Billich; F Hammerschmid; G Werner; B Wolff; P Peichl; G Palfi; W Schnitzel; E Mlynar
Journal:  J Virol       Date:  1995-02       Impact factor: 5.103

Review 3.  Regulation of human immunodeficiency virus type 1 and cytokine gene expression in myeloid cells by NF-kappa B/Rel transcription factors.

Authors:  A Roulston; R Lin; P Beauparlant; M A Wainberg; J Hiscott
Journal:  Microbiol Rev       Date:  1995-09

4.  Inhibition of human immunodeficiency virus type 1 replication by SDZ NIM 811, a nonimmunosuppressive cyclosporine analog.

Authors:  B Rosenwirth; A Billich; R Datema; P Donatsch; F Hammerschmid; R Harrison; P Hiestand; H Jaksche; P Mayer; P Peichl
Journal:  Antimicrob Agents Chemother       Date:  1994-08       Impact factor: 5.191

Review 5.  Host factors influencing susceptibility to HIV infection and AIDS progression.

Authors:  Juan Lama; Vicente Planelles
Journal:  Retrovirology       Date:  2007-07-25       Impact factor: 4.602

6.  Membrane-Active Sequences within gp41 Membrane Proximal External Region (MPER) Modulate MPER-Containing Peptidyl Fusion Inhibitor Activity and the Biosynthesis of HIV-1 Structural Proteins.

Authors:  Si Min Zhang; Alenka Jejcic; James P Tam; Anders Vahlne
Journal:  PLoS One       Date:  2015-07-31       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.